Skip to content

CRT Pilot Study for Children With Heart Failure

Cardiac Resynchronization Therapy for Children and Adolescents With Advanced Hearth Failure: A Pilot Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00585065
Enrollment
7
Registered
2008-01-03
Start date
2006-01-31
Completion date
2016-01-31
Last updated
2023-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pediatric Heart Failure

Brief summary

To collect information on pediatric patients receiving Cardiac Resynchronization Therapy (CRT) with permanent biventricular pacing (BVP) as a method of treating chronic heart failure.

Interventions

The purpose of this study is to collect information on patients with chronic heart failure who have already been identified by their physician as candidates for CRT. All tests, including device implantation are standard of care for patients undergoing CRT. The only test involved in this study that is not standard of care is the quality of life questionnaire. Patients who undergo CRT system implant will be followed post-implant (up to 1 week), and at one month, three months, six months and twelve months. The only test involved in this study that is not standard of care is the quality of life questionnaire.

Sponsors

University of Utah
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Chronic and severe heart failure, NYHA class III or IV 2. Patients optimized and stable on diuretics and afterload reducing agents (with or without inotropes) for at least 1 week prior to enrollment 3. Chronic systemic ventricular dysfunction as defined in the protocol. 4. Intra ventricular conduction delay defined by spontaneous QRS duration \> ULN for age. 5. All children from 1 to 18 years of age, both male and female, and all ethnic backgrounds. 6. Signed and dated informed consent. 7. Able to receive pectoral or abdominal implant.

Exclusion criteria

1. Suspected acute myocarditis. 2. Significant ventricular dysfunction, secondary to acquired or congenital heart defects amenable to surgical correction. 3. Acute coronary syndrome. 4. Adolescents who are pregnant. 5. Patient with BVP device implanted previously. 6. Patient has had prior/past heart transplantation.

Design outcomes

Primary

MeasureTime frameDescription
Collection of quality of life information using the Pediatric Quality of Life Inventory 4.0 (PedsQl v4.0) in children and adolescents with chronic, advanced heart failure (defined by NYHA Functional Classification).Within 30 days of CRT implant to 12 months post implantComposed of 23 items comprising 4 dimensions. 5-point Likert scale from: 0 (Never) to 4 (Almost always). Higher scores = Better health related quality of life (HRQOL)
Collection of survival information using the Pediatric Quality of Life Inventory 4.0 (PedsQl v4.0) in children and adolescents with chronic, advanced heart failure (defined by NYHA Functional Classification).Within 30 days of CRT implant to 12 months post implantComposed of 23 items comprising 4 dimensions. 5-point Likert scale from: 0 (Never) to 4 (Almost always). Higher scores = Better health related quality of life (HRQOL)

Secondary

MeasureTime frameDescription
Echocardiographic measurement predictors of positive response to cardiac resynchronization therapy (CRT) in children and adolescent patients according to the American Society of Echocardiography guidelinesWithin 30 days of CRT implant to 12 months post implantDescribe the relationship between echocardiographic measures and subject response to CRT

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026